SCHEMBL7218970

SCHEMBL7218970

Fc1ccc(I)cc1F.O=Cc1ccc(-c2ccc(F)c(F)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.54
CYP17A1 P05093 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
DRD1 P21728 2/20 0.40
HSD17B10 Q99714 1/20 0.36
ERN1 O75460 5/20 0.36
PTGS1 P23219 1/20 0.34
NFE2L2 Q16236 2/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2A6 P11509 1/20 0.32
ALDH5A1 P51649 1/20 0.32
ABAT P80404 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3457040 0.89 KIF11 (0.65) KIF11CYP17A1CYP11B1CYP11B2DRD1
SCHEMBL12795395 0.79 CYP17A1 (0.47) KIF11CYP17A1CYP11B1CYP11B2HSD17B10
SCHEMBL27566614 0.79 KDM4E (0.59) KIF11HSD17B10ERN1NFE2L2ALDH5A1
SCHEMBL12037310 0.77 DRD1 (0.47) KIF11DRD1HSD17B10ALDH1A1CYP2A6
SCHEMBL2012322 0.77 KIF11 (0.54) KIF11DRD1HSD17B10ERN1PTGS1
SCHEMBL22459322 0.74 KIF11 (0.61) KIF11DRD1ERN1PTGS1NFE2L2
SCHEMBL80458 0.74
SCHEMBL29481423 0.74
SCHEMBL16037967 0.74 KIF11 (0.59) KIF11DRD1HSD17B10ERN1PTGS1
SCHEMBL2009103 0.73 KIF11 (0.54) KIF11DRD1HSD17B10PTGS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326841-A1 PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS SmithKline Beecham P.L.C. (GB) 2003-07-16 EP disclosed
WO-2002030904-A1 PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM P.L.C. (GB) 2002-04-18 WO disclosed